Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness

By sjmartinez • August 22, 2024

Hatziapostolou M, Koutsioumpa M, Zaitoun AM, Polytarchou C, Edderkaoui M, Mahurkar-Joshi S, Vadakekolathu J, D'Andrea D, Lay AR, Christodoulou N, Pham T, Yau TO, Vorvis C, Chatterji S, Pandol SJ, Poultsides GA, Dawson DW, Lobo DN, Iliopoulos D. Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. Gastro Hep Adv. 2024 Apr 24;3(5):687-702. doi: 10.1016/j.gastha.2024.04.005. PMID: 39165427; PMCID: PMC11330932.

Tags: Cedars Sinai DoM, Digestive Diseases, DNA methylation, epigenetics, HNF4A, pancreatic cancer, Publications

Examining Explicit Stereotype Perceptions of Colorectal Cancer Screening and Diagnosis in the Hispanic Community

Foley A, Luna-Lupercio B, Capaldi JM, Wiens-Cook G, Calsavara V, Surani Z, Salvy SJ, Figueiredo JC, Haile R, Cáceres NA, Shirazipour CH. Examining Explicit Stereotype[...]

Barriers and solutions in women’s health research and clinical care: a call to action

Regensteiner JG, McNeil M, Faubion SS, Bairey-Merz CN, Gulati M, Joffe H, Redberg RF, Rosen SE, Reusch JE, Klein W. Barriers and solutions in women's[...]

Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials

Golub IS, Thummala A, Morad T, Dhaliwal J, Elisarraras F, Karlsberg RP, Cho GW. Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and[...]